SRI Logo
Therapeutic Areas
Plus buttonOncology
Plus buttonInfectious Disease
Plus buttonImmunology and Inflammation
Plus buttonNeuroscience
Plus buttonVaccine Development
Plus buttonPreclinical Development
Preclinical Development Planning
Cell and Molecular Imaging Services
Clinical Laboratory Services
Out-Licensing Opportunities
NIMH Toxicology Program
Center for Advanced Drug Research (CADRE)
Resources
Government Clients
Contact Biosciences
Biosciences Division
Spacer
    

Spacer
         
  SRI Logo

Contact SRI Biosciences

Biosciences Partnering and Licensing Opportunities

SRI has a number of drug candidates that are available for partnering. SRI owns the intellectual property surrounding these compounds.

SRI's Drug Development Pipeline SRI drug candidate 16157 non-confidential overviewSRI drug candidate 16388 non-confidential overviewSRI drug candidate 13654 non-confidential overviewSRI drug candidate 13688 non-confidential overview SRI drug candidate TAS108 non-confidential overview SRI drug candidate tirapazamine non-confidential overview

For additional information, contact:
Jim Rurka
Executive Director, Biosciences Commercialization
650-859-5365
james.rurka@sri.com

       Last Updated Feb 1, 2011

 

About Us  Vertical divider  R&D Divisions  Divider  Careers  Divider  Newsroom  Divider  Contact Us
©2012 SRI International 333 Ravenswood Avenue, Menlo Park, CA 94025-3493
SRI International is an independent, nonprofit corporation. Privacy policy